2.6
2023

Clavulanic acid sensitization seems more involved in cutaneous than systemic reactions in amoxicilline-clavulanate drug reactions

Show more: Authors information and Publication history
Authors Information

1Department of Internal Medicine, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
2Allergy and Clinical Immunology Residency, University of Milan, Milan, Italy 

History

Published: 09 February 2023
Accepted: 05 February 2023
Received: 22 September 2023

SUMMARY

BLs allergy is considered a major health issue, as BLs are the most frequently involved in drug allergic reactions. Amoxicillin (AX) is the most frequently involved drug in sensitization among all BLs. AX is commercialized alone or combined to clavulanic acid (CLA) in order to increase the antibiotic spectrum. The growing prescriptions of AX-CLA formulations contributed to increase the role of CLA as an allergy inducer. At present, little is known about the clinical characteristics of hypersensitivity reactions to clavulanate. The aim of this study was to assess the difference in the prevalence of cutaneous vs systemic reactions in patients who had a documented history of allergic reactions to amoxicillin-clavulanate and tested positive for clavulanate or penicillin/amoxicillin. Our study suggests that patients who presented only muco-cutaneous reactions were more often sensitized to CLA rather than AX. 

KEY WORDS
Clavulanic acid; amoxicillin; drug allergy, delayed reaction; systemic reaction.

Table of Content: Online First

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024